US Regulators Authorize COVID-19 Vaccine Booster Doses for 16- and 17-Year-Olds The decision drew immediate pushback, with experts noting that young, healthy people are at low risk of severe COVID-19 and at elevated risk of heart inflammation following vaccination.

By The Epoch Times

This story originally appeared on The Epoch Times

Newsday LLC | Getty Images

U.S. drug regulators on Thursday authorized booster doses of Pfizer's COVID-19 vaccine for 16- and 17-year-olds.

The Food and Drug Administration (FDA) cited in its announcement data showing the vaccine becomes significantly less effective over time.

"Since we first authorized the vaccine, new evidence indicates that vaccine effectiveness against COVID-19 is waning after the second dose of the vaccine for all adults," Dr. Peter Marks, a top FDA official, said in a statement.

"A single booster dose of the vaccine for those vaccinated at least six months prior will help provide continued protection against COVID-19 in this and older age groups," he added.

The decision drew immediate pushback, with experts noting that young, healthy people are at low risk of severe COVID-19 and at elevated risk of heart inflammation following vaccination.

"I understand that the third dose will boost their level of neutralizing antibiotics. But if the goal of this vaccine is protection against serious illness—which is a reasonable goal and it's the goal for every other vaccine—two doses already do that. So why do we need a third dose? Where's the evidence that a third dose will protect children to a greater extent against serious illness?" Dr. Paul Offit, director of the Vaccine Education Center, professor of pediatrics at Children's Hospital of Philadelphia, and a member of the FDA's vaccine advisory panel, told The Epoch Times.

"And that evidence has to be there because the 16- and 17-year-old is at highest risk of myocarditis," Offit added.

Dr. Mike Saag said he hasn't seen specific data for the age group but that the move makes sense given the waning effectiveness of vaccines.

"I think that all individuals, regardless of age, will ultimately receive "booster' shots 6 months after completion of the initial 2-dose vaccination. The biology and epidemiologic data support this. What remains unknown is how long protective immunity will last after receiving the third shot," Saag, a professor at the University of Alabama at Birmingham's Department of Medicine, told The Epoch Times in an email.

Data from approximately 200 people who got a Pfizer booster was used as evidence for the authorization, the FDA said.

Real-world data that has become available on the post-vaccination conditions "enabled the FDA to reassess the benefits and risks of the use of the vaccine in a wider population" and the agency determined the benefits of a booster outweigh the risks.

The FDA did not immediately provide the data and Offit said he was not aware of such data.

Pfizer CEO Albert Bourla cheered the news. "While new variants, including Omicron, emerge across the globe, we believe that the best way to minimize the spread of COVID-19 and any future variants is getting all eligible people fully vaccinated with the first two dose series and a booster dose as recommended," he said in a statement.

The FDA authorized the boosters without input from its vaccine advisory panel. It also avoided convening the panel before authorizing boosters for everybody 18 and older.

There would have been no benefit from soliciting advice from the committee, the FDA said.

The Centers for Disease Control and Prevention (CDC) now must decide whether the 16- and 17-year-olds "may" or "should" get a third Pfizer dose.

The CDC did not immediately respond to a request for comment.

By Zachary Stieber

Zachary Stieber covers U.S. news and stories relating to the COVID-19 pandemic. He is based in Maryland.

Wavy Line

The Epoch Times, founded in 2000, is headquartered in Manhattan, New York, with a mission to provide independent and accurate information free of political bias or corporate influence. The organization was established in response to censorship within China and a lack of global awareness regarding the Chinese regime's repression of the spiritual practice Falun Gong.

The Epoch Times is a widely read newspaper that is distributed in 33 countries and is available in 21 languages. The publication has been critical in providing balanced and detailed reporting on major global events such as the 2003 SARS pandemic and the 2008 financial crisis. Notably, the organization has played a key role in exposing corruption inside China.

Aside from its human rights coverage, The Epoch Times has made significant contributions in a variety of fields. It has received praise for its in-depth analysis and expert perspectives on business, the economy and U.S. politics. The newspaper has also received praise for its broad coverage of these topics.

A series of editorials titled "Nine Commentaries on the Communist Party" appeared in The Epoch Times in 2004. It asserts that freedom and prosperity in China can only be achieved by eliminating the Communist Party, which violated China's cultural and spiritual values. In addition, the organization led the Tuidang movement, which resulted in over 400 million Chinese citizens quitting the Communist Party. In spite of this, 90% of websites referring to the "Nine Commentaries" were blocked by the Chinese regime.

The Epoch Times has been at the forefront of investigating high-level corruption cases within the Chinese regime, with its reporters taking significant risks to uncover these stories. The organization has received several awards for its investigative journalism.

The organization has received several awards for its investigative journalism. For more, visit

Editor's Pick

She's Been Coding Since Age 7 and Presented Her Life-Saving App to Tim Cook Last Year. Now 17, She's on Track to Solve Even Bigger Problems.
I Helped Grow 4 Unicorns Over 10 Years That Generated $18 Billion in Online Revenues. Here's What I've Learned.
Want to Break Bad Habits and Supercharge Your Business? Use This Technique.
Don't Have Any Clients But Need Customer Testimonials? Follow These 3 Tricks To Boost Your Rep.
Why Are Some Wines More Expensive Than Others? A Top Winemaker Gives a Full-Bodied Explanation.

Related Topics

Business News

Oscar Mayer Is Changing the Name of Its Iconic Wienermobile

The company is slamming the brakes on its wiener on wheels and rolling out a new meaty ride.


Take Your Social Media Earning Potential Sky-High With This $79.97 Quadcopter

Get this beginner-friendly drone for a great price for Father's Day.

Health & Wellness

Sleep Better, Snore Less, and Stay Cool with This Tech-Packed Pillow, Now $49.99

Let technology help you sleep better with this 8-in-1 cooling pillow.

Business News

TikTok Influencer Reveals She Makes $350,000 a Month on OnlyFans. 'Absolutely Unreal.'

When Tara Lynn promoted her OnlyFans page on TikTok, she saw her income more than double.

Business News

'All Hell Is Going to Break Loose': Barbara Corcoran Issues Warning About Real Estate Market, Interest Rates

The "Shark Tank" star appeared on FOX Business' "The Claman Countdown" this week.


The Real Reason Why The Return to Office Movement is Failing is Revealed in New Study

There is a vivid sign of the disconnect between employees and their workplace, a glaring indication that companies need to revise their scripts to improve their hybrid and remote work policies.